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1. Introduction 
The increasing amount of information available 
relating to the structure and activity of yeast mito- 
chondria has made feasible the use of a genetic ap- 
proach to the problem of the mechanisms of respira- 
tion and oxidative phosphorylation by isolating mu- 
tants with lesions in mitochondrial metabolism [l] . 
Such mutants are usually detected by either their ina- 
bility to grow on non-fermentable carbon sources, 
their staining reaction to dyes feeding into the elec- 
tron transport chain, their spectral characteristics or 
their resistance to drugs which affect oxidative phos- 
phorylation or electron transport [2,3] . 
Some of the mutants so far isolated, such as the cyto- 
plasmic petites and a number of nuclear gene mutants 
with a similar phenotype are unsuitable for biochemi- 
cal analysis of energy coupling reactions or respiration 
due to the large extent of the biochemical lesions. 
However, other more specific mutants [4-71 have 
been reported. 
The purpose of the investigation was to attempt to 
define a series of mutants in which mitochondrial 
function relating to oxidative phosphorylation had 
been altered, and to carry out a systematic genetic and 
biochemical study on them. The results presented relate 
to a series of 50 mutants of Saccharomyces cerevisiae 
which were resistant to concentrations of oligomycin 
4-20 fold greater than that inhibiting the non- 
resistant strain. The cross resistance to other inhibitors 
of oxidative phosphorylation such asN, N1 -dicyclo- 
hexylcarbodiimide (DCCD) and aurovertin was investi- 
gated. 
2. Materials and methods 
2. I. Stmins and nomenclature 
Two heterothallic strains of S. cerevisiae D22 
(adz, (Y, p’> and D6 (arg, met, p’) obtained from 
Dr.D.Wilkie were used. All mutants were derived from 
either of these two haploids strains whose drug resis- 
tance is shown in table 1. All mutants derived from D6 
have that number as a prefix and similary with D22. 
Series A, B, C, refer to whether the mutants were 
isolated from oligomycin plates containing 2.5, 5.0 or 
10 pg/ml of the drug, respectively. The two parental 
strains D6 and D22 served as sensitive testers through- 
out the genetic studies. 
2.2. Media 
The normal growth media for the haploid strains 
were : 
YEPG: 2% peptone, 1% yeast extract, 2% glu- 
cose, and 2% agar (oxoid No. 3); 
YEPGly: 2% peptone, 1% yeast extract, 4% gly- 
cerol, 2% agar; 
YEPEtOH: 2% peptone, 1% yeast extract, 0.5% etha- 
nol (added after autoclaving ), 2% agar. 
The liquid growth media used normally were as 
above but minus the agar. 
The synthetic media used for genetic studies on 
diploids were: 
MMG: Wickerham minimal medium glucose 
PI; 
MMGly: Wickerham minimal medium glycerol - 
as above but 4% glycerol instead of glu- 
cose as the carbon source. 
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MMPDM: minimal medium for petite determina- Table 1 
tion - as above but 4% glycerol and Resistance to oligomycin and cross resistance to aurovertin. 
0.5% glucose served as the carbon source. 
Agar was added when necessery at a con- 
Tolerance of Tolerance of Tolerance of 
Strain haploid to 
centration of 1.5% [Ionagar No.2 Oxoid] . 
diploids haploid to 
oligomycin (OL’ x OLs) aurovertin 
Haploid strains were cultivated in the 
above media supplemented with either 
adenine (10 mg/l) or arginine and 
methionine (10 mg/l) 
Drug plates were prepared by adding the drug as an 
ethanolic solution to autoclaved YEPGly agar cooled to 
SO”. All drug plates were used within 24 hr of pouring. 
Oligomycin was purchased from Sigma Chemical Co., 
carbonyl cyanide phenyl hydrazone (CCCP) from Cal- 
biochem, paromomycin was kindly donated by Parke 
Davis and Co. Ltd., erythromycin a kind gift from Eli 
Lilly, whilst spiramycin was generously donated by May 
and Baker. Aurovertin was a gift from Professor H.A. 
Lardy. 
2.3. Isolation of mutants and testing for oligomycin 
resistance 
Oligomycin resistant mutants were isolated by ultra- 
violet irradation for 80 set (10% viability) of a cell 
suspension containing 2 X 10’ cells/ml followed by 
plating out of 4 X lo6 cells onto YEPGly plates con- 
taining 2.5,5.0 or 10.0 &ml of oligomycin. Colonies 
that grew after incubation for 5 days at 30’ were iso- 
lated, streaked out onto YEPGly plates containing 
2.5 I.cg/ml oligomycin and single colonies isolated. 
These colonies were subsequently tested for their 
degree of resistance by replica plating and by plating 
out cells onto drug plates. Growth was examined after 
3 days incubation at 30”. 
2.4. Aurovertin resistance 
Assays for aurovertln resistance were carried out 
using YEPGly plates on which were spread approx. 
1000 cells. 400 E.cg aurovertin were added as an etha- 
nolic solution to a central well cut in the plates and 
inhibition zones were measured after 3-4 days. Con- 
trols were run using ethanol. 
2.5. DCCD resistance 
Resistance of the strains was tested by plating out 
approx. 1000 cells, onto DCCD containing plates of 
minimal medium supplemented with adenine, arginine 
and methionine and with either ethanol or glycerol as 
to oligomycin 
D22A2 
D22A3 
D22A4 
D22AS 
D22A7 
D22A9 
D22A12 
D22A18 
D22B9 
D22B15 
D22B16 
D22B21 
D6Al 
D6A4 
2.5 
10.0 
> 10.0 
> 10.0 
> 10.0 
> 1::: 
> 1;: 
> 1o:o 
> 10.0 
> 10.0 
> 1;: 
N.T. 
2.5 
2.5 
2.5 
1.0 
2.5 
1.0 
1.0 
2.5 
1.0 
> 1::: 
> 1::: 
Resistant 
N.T. 
Resistant 
Resistant 
N.T. 
N.T. 
N.T. 
Resistant 
Resistant 
Resistant 
Resistant 
N.T. 
N.T. 
Resistant 
D6B2 > 1o:o 0.5 N.T. 
D22 0.5 - Nil 
(D6 x D22) 1.0 N.T. 
D6 0.5 - Nil 
N.T. = Not tested 
The level of oligomycin tolerance is defined as the maximum 
concentration of oligomycin permitting growth of the strain. 
Levels of oligomycin used were 0.5, 1.0, 2.5,5.0, 10.0 &ml. 
Aurovertin resistance is defined as a failure to form inhibition 
zones when 400 ng aurovertin were added to a centre well. 
carbon source. The media were buffered at either 
pH 7.3 or pH 6.0 using 0.1 M phosphate buffer. 
Growth at 30” was scored after 5 days. 
2.6. Petite frequency 
The effect of oligomycin on petite frequency was 
tested by growth in MMG + supplements in the pre- 
sence and absence of oligomycin. Growth tubes were 
shaken for 48 hr at 30’. Petite frequency was estima- 
ted using the tetrazolium overlay technique [lo]. 
2.7. Genetic analyses 
Crosses were performed by the mass mating 
technique and the resulting zygotes were selected 
on MMG. Synchronised zygotes were obtained 
following a modified procedure of Jakob [9] . As 
diploids obtained in the initial 4 hr after mating grew 
only poorly on MMGly, oligomycin resistance was 
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assayed using MMPDM plates containing oligomycin 
and colonies containing resistant cells identified by 
the presence of tetrazolium positive papillae. Diploids 
obtained after 4 hr were assayed using MMGly oligo- 
mycin plates. 
3. Results and discussion 
The 50 oligomycin resistant mutants isolated showed 
degrees of resistance (table 1) varying from 2.5 to 
> 10 pg/ml oligomycin as compared to sensitivity to 
0.5 I.cg/ml oligomycin exhibited by the parental strain. 
The mutants appeared perfectly stable for 9 months 
after isolation. All oligomycin resistant mutants tested 
showed cross resistance to aurovertin when assayed as 
described in table 1. The level of aurovertin necessary 
to inhibit the oligomycin sensitive strains D6 and D22 
is at least 40 times greater than the level of oligomycin 
required for inhibition; 20 &g/ml of aurovertin failed 
to inhibit the growth of either strain. 
None of the oligomycin resistant strains showed any 
cross resistance to erythromycin, paromomycin, spira- 
mycin, CCCP or 2,4-dinitrophenol. The resistant 
strains were tested using a range of concentrations of 
these compounds from l-1000 times the minimal con- 
centration necessary to inhibit the growth of the oligo- 
mycin sensitive strains, D6 and D22. 
N, N’-Dicyclohexylcarbodiimide (DCCD) is a potent 
inhibitor of oxidative phosphorylation and energy 
transfer processes in animal mitochondria [ 1 I] and in 
yeast cells [ 121 and is readily available in contrast to 
aurovertin. Genetic studies are complicated by its insta- 
bility in aqueous solution at acid pH but it is reason- 
ably stable at neutral pH. Consequently studies of 
DCCD resistance were carried out at pH 7.3 rather than 
at pH 6.0. At pH 7.3 the oligomycin sensitive strains 
D6 and D22 are inhibited by 0.5 PM DCCD with gly- 
cerol as the carbon source (table 2) but required 125 
PM DCCD when glucose was the carbon source. 
Many of the oligomycin resistant strains showed a 
lo-25 fold increased resistance to DCCD when grown 
on glycero1, compared to the parental strains D6 and 
D22. It is not possible at this stage to state that all 
oligomycin resistant strains show cross resistance to 
DCCD because of poor growth of some strains at 
pH 7.3. 
When grown on glucose as carbon source at both 
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Table 2 
Sensitivity of yeast strains to DCCD. 
Tolerance Tolerance of haploids to DCCD bM) 
Strain 
of haploids 
to oligo- Carbon source 
mycin 
(&ml) Glycerol Glucose 
- 
pH 5.8 pH 7.3 
D6 0.5 <o.s 
D22 0.5 <0.5 
D22BlO 5.0 ++++ 
D22B14 2.5 ++ 
D22B21 > 10.0 + 
D22B8 > 10.0 ++ 
D22Bl6 >lO.O +++ 
pH 6.0 
20.0 
20.0 
pH 7.3 
> 125.0 
> 125.0 
++++ Resistant to > 10 I.~M DCCD 
+++ Resistant to 5.0- 10 NM DCCD 
++ Resistant to 2.5-5.0 PM DCCD 
+ Resistant to 1.0-2.5 MM DCCD 
Media used were MMG and MMGly and adenine, arginine, 
and methionine. All media were made up in 0.1 M phosphate 
buffer. DCCD was added as a freshly made ethanolic solution 
to autoclaved media cooled to 50”. 
pH 6.0 and pH 7.3 there was no correlation between 
oligomycin resistance and DCCD resistance. At pH 6.0 
with glycerol there was again no correlation between 
oligomycin and DCCD resistance. This may be due to: 
(a) DCCD having a specific effect on energy conserva- 
tion reactions at neutral pH only; (b) hydrolysis of 
DCCD at pH 6.0 leading to variable concentrations of 
DCCD within the yeast cell; (c) variable hydrolysis of 
DCCD at pH 6.0 leading to reaction products which 
affect energy conservation reactions but at a different 
locus to DCCD and oligomycin. 
The results on cross resistance to aurovertin and 
DCCD taken together with evidence that other oli- 
gomycin resistant mutants show cross resistance to 
venturicidin [2a, b] - all inhibitors affecting oxidative 
phosphorylation despite their different molecular 
structures - strongly suggest hat the resistance to 
these mutants is not due to changes in cell perme- 
ablility but to a change at the locus of action of these 
inhibitors, the mitochondrial ATP synthetase com- 
plex or the interaction of this complex with the mito- 
chondrial membrane. Supporting evidence for this 
view has come from studies in this laboratory on the 
oligomycin sensitivity of ATPase in yeast submito- 
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Table 3 Table 4 
Effect of oligomycin on petite frequency resistant and sen- Resistance of diploids derived from oligomycin resistant x 
sitive strains oligomycin sensitive crosses 
Strains 
Level of Oligomycin Increase in % 
oligomycin concentration petite frequency 
Tolerance used in mduc- relativ to 
tion control 
&g/ml) 
Strain 
No. of No. of No. of 
colonies resistant non- 
colonies resistant 
colonies 
D6 1.0 5 +300 
D22 
>I”d”o 
10 +500 
D22A4 5,lO + 30 
D22A5 >10:0 10 +380 
D22A7 >lO.O 10 * 30 
D22AlS >lO.O 10 + 30 
D22BlO 5 
D22B16 >15dpo 10 
f 30 
* 30 
D220C410 >lO.O 10 + 30 
D6B2 >lO.O 10 +170 
D22A3 x D6 23 0 0 23 
D22A4 x D6 78 0 0 18 
D22A7 x D6 31 0 0 31 
D22A12 x D6 120 0 0 120 
D22B9 x D6 422 0 0 422 
D22Bl x D6 234 0 60 174 
D6Al x D22 38 0 5 33 
D6A4 x D22 248 11 3 234 
D6Bl x D22 24 0 0 24 
D6B2 x D22 67 0 23 44 
- 
A 1% inoculum of mid log phase glucose grown cells was 
inoculated into minimal medium + supplements containing 
oligomycin and grown with shaking for 48 hr, at 30’. Control 
tubes contained no oligomycin but equivalent amounts of 
EtOH to that added to the ohgomycin growth tubes. Cells 
were plated onto YEPG and incubated for 5 days at 30°. 
Petites were indentified using a tetrazolium overlay [lo]. 
Diploid colonies were obtained by mass mating followed 
by plating out and auxotrophic selection. Resistance to 2.5 rg 
and 5.0 pg/ml oligomycin was tested by replica plating 
chondrial particles. 
ATPase in submitochondrial particles from the 
parental strain D22 is inhibited 50% by 8 ng oligo- 
mycin/mg/protein whereas the ATPase activity in 
submitochondrial particles derived from strains D22A4 
and D22B9 are inhibited 50% by 50 pg oligomycin/mg/ 
protein and 10% by 750 c(g oligomycin/mg/protein 
respectively (J.R.Turner, personal communication). 
resistant strains tested (D22A5 and B6B2) showed an 
increase in petite frequency when grown in the pres- 
ence of oligomycin. This difference in responce of the 
resistant and sensitive strains does not seem to be due 
to inhibition of the sensitive strains at the end of the 
glycolytic growth phase in the presence of oligomycin 
[ 131. The results show that strains D22A5 and D6B2 
differ from the other strains tested and suggest hat at 
least in these two resistant strains oligomycin resistance 
is not due to its altered permeability. 
3.2. Genetic studies 
Similarly, studies on mitochondrial membrane pro- 
teins from oligomycin sensitive and resistant strains 
show marked differences when examined by gel- 
electrophoresis (Broughall and Avner, to be published). 
The significance of these observations and their rela- 
tion to changes in the components of the ATP synthe- 
tase complex and/or its interaction with the energy 
conservation system of the mitochondrial membrane 
are being investigated. 
3.1. Effect of oligomycin of petite frequency 
Table 3 shows that the petite frequency of the 
oligomycin sensitive strains D6 and D22 increase 
at least three fold when these cells are grown in the 
presence of oligomycin. In contrast, only two of the 
Diploids obtained by mass mating resistant strains 
to a p’ sensitive tester when analysed by plating out 
showed varying levels of resistance (table 1). Most of 
the diploids appeared to exhibit resistance intermedi- 
ate between that of the parental strains, but some 
exhibited resistance no greater than obtained on 
crossing the two non resistant strains D6 and D22 and 
others-within the limits of the concentrations tested 
appeared to have levels of resistance as high as that of 
the haploid resistant strain from which they were 
derived. Single diploid colonies were obtained from 
some of the strains and examined by replica plating. 
All the strains so far tested gave either mixed colo- 
nies consisting of resistant and non resistant cells, or 
mixtures of resistant and non resistant colonies 
No. of 
mixed 
colonies 
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Fig. 1. Cell density and % resistant diploids plotted against 
time. Synchronised zygotes were isolated folowing the pro- 
cedure of Jakob [9] A 1% inoculum of these zygotes was 
inoculated into MMG and grown at 30’. Aiiquotswere taken 
for estimation of cell density, and number of resistant cells. 
Early cell counts were estimated on MMG plates and resistance 
estimates made using oligomycin containing MMPDM plates 
which were overlayed with tetrazolium chloride and colo- 
nies derived from initially resistant cells identified by the pres- 
ence of tetrazolium positive papillae. Later resistance sti- 
mates were made using MMGly and oligomycin plates, and 
cell counts made using MMGly plates. e-e: Log of % No. of 
resistant cells/ 2.5 mg/ml; O--O: Log of % No. of resistant 
cells 5.0 mg/ml; 4-a: Log cell No/ml 
(table 4). This behaviour strongly suggests the presence 
of cytoplasmic determinants and this is currently 
being checked by tetrad analysis. Similar results have 
been reported by Stuart [7]. Mixed colonies were ob- 
tained in the case of strains resistant to > 10 pg/ml 
oligomycin whether or not resistance of the diploids 
was tested at the 2.5 or 5.0 pg/ml level. However, in 
the latter case, less resistant growth was observed and 
this has been comfirmed by qantitative aliquot plating 
of diploids obtained by mass mating in which far 
fewer resistant colonies grew after plating onto 5.0 
pg/ml MMGly oligomycin plates than 2.5 pg/ml 
MMGly oligomycin plates. This decrease in the number 
of resistant cells as the oligomycin concentration was 
raised is not due to some zygotes giving rise to cells 
resistant to 5.0 pg/ml oligomycin and other zygotes 
giving rise to cells resistant to 2.5 pg/ml since, on 
replica plating diploid clones of D6 X D22B9, all 
the individual clones showed cells resistant to both 
2.5 and 5.0 lug/ml oligomycin. The frequency of cells 
resistant to 2.5 and 5.0 pg/ml oligomycin however 
clearly varied from clone to clone. 
The kinetics of the loss of resistance in diploids 
are shown in fig. 1. The number of resistant colonies 
in a cross of a resistant strain with a sensitive tester 
falls continuously with increasing number of genera- 
tions; the lower transmission of resistance at the 5.0 
I.cg/ml evel than at the 2.5 Irg/ml level is shown, even 
though during the first generations of growth after 
mating the number of cells showing resistance to both 
levels remains approximately the same. The size of 
colonies arising on the plates appears rather hetero- 
geneous and this could be for three reasons: first, the 
active oligomycin concentration on the plates may 
fall, leading to an increasing number of diploids since 
more diploids appear resistant at lower levels of oligo- 
mycin; second, the number of resistant cytoplasmic 
particles, perhaps resistant mitochondria per cell, 
may influence growth rate even where there are 
sufficient to support cell growth; third, different 
clones seem to have different transmission rates of 
resistance and this will influence colony size on 
growth plates. A simple explanation for the results in 
fig. 1 is that a higher number of resistant “particles” 
are necessary for oligomycin resistance at the 5 pg/ml 
level than at the 2.5 pg/rnl level. As the resistant 
strain used D22B9 is resistant to > 10 Ccg/ml oligo- 
mycin all the derived diploids would initially be resistant 
to greater than 5 &ml oligomycin but continued 
segregation of resistant and sensitive “particles” 
would lead to a drop in the number of resistant cells 
and a faster decline in the relative numbers of cells 
resistant to the higher levels of oligomycin would be 
expected. 
If the behaviour of strain D22B9 is typical of other 
oligomycin resistant mutants then rigorously stan- 
dardised growth conditions are necesarry when com- 
parisons are made of the levels of resistance of, for 
example, petites derived from resistant strains [ 141 
and in determining the level of resistance of diploids 
derived from resistant strains. 
206 
Volume 10, number 3 FEBS LETTERS October 1970 
Acknowledgements 
P.R.A. thanks the Medical Research Council for a 
Research Studentship. 
References 
[I] FSherman, in: Methods in Enzymology, Vol. 10, eds. 
R.W.Estabrook and M.E.PuIlman (Academic Press, 
New York, 1967) p. 610. 
[2a] J.H.Parker, I.R.Trimble Jnr. and J.R.Mattoon, Biochem. 
Biophys. Res Commun.‘33 (1968) 590; 
[Zb] K.D. Stuart, Biochem. Biophys. Res. Commun. 39 (1970) 
1045. 
[ 31 R.A.Butow and M.Zeydel, J. Biol. Chem. 243 (1968) 
2545. 
[4] J.Beck, J.R.Mattoon, D.C.Hawthorne and F.Sherman, 
Proc. Natl. Acad. Sci. U.S. 60 (1968) 186. 
[5] J.H.Parker and J.R.Mattoon, J. Bacterial 100 (1969) 647. 
[ 6] L.Kovac, T.M.Lachowicz and P.P.Slonimski, Science 158 
(1967) 1564. 
[7] K.Wakabayashi and N.Gunge, FEBS Letters 6 (1970) 302. 
[8] L. Wickerham, J. Bacterial. 52 (1946) 293. 
[9] H.Jakob, Genetics 52 (1965) 75. 
[lo] MOgur, R.St.John and S.Nagai, Science 125 (1957) 928. 
[ll] R.B.Beechey, A.M.Roberton, T.Holloway and I.G.Knight, 
Biochemistry 6 (1967) 3867. 
[ 121 L.Kovac, T.Galeotti and B.Hess, Biochim. Biophys. 
Acta 153 (1968) 715. 
[ 131 P.R.Avner and D.E.Griffiths, unpublished observations. 
[14] E.B.Gingold,G.H.Saunders,H.B.LukinsandA.W.Linnane, 
Genetics 62 (1969) 735. 
207 
